Idorsia Company
Idorsia is a biopharmaceutical company based in Switzerland that aims to discover, develop and commercialize innovative medicines to help more patients. They have a strong scientific core and specialize in the discovery, development and commercialization of innovative small molecules to transform the horizon of therapeutic options. Their goal is to become a leading biopharmaceutical company.
Estimated Revenue:
CHF 1,188 million
Funding Status:
IPO
Employee Number:
1001-5000
Industry:
BioTech
Headquarters:
Allschwil
Founded Date:
2017
Total Funding:
$1.4B
Technology:
Small Molecules